
The company says the innovation, built on its CoreNhanced BioJourney platform, is designed for beverage and gummy formats.
Nutritional Outlook interviews Vivien Sheehan, vice president of business development for Kerry to discuss the opportunity the latest GLP-1 drug craze opens up for supplement brands, and the ways in which brands can help GLP-1 drug users while they're on the drugs and after.






